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Abstract  
Background: Although colposcopy is the leading follow-up option for women with abnormal 
cervical cytology, little is known about its psychological consequences. 
 
Objectives: We performed a systematic review to examine: (1) what, if any, are the adverse 
psychological outcomes following colposcopy and related procedures; (2) what are the 
predictors of adverse psychological outcomes post-colposcopy; and (3) what happens to 
these outcomes over time. 
 
Search strategy: Five electronic databases (PubMed, PsychINFO, CINAHL, Web of Science, 
Scopus) were searched for studies published in English during January 1986-February 
2014. 
 
Selection criteria: Eligible studies assessed psychological wellbeing at one or more time-
points post-colposcopy. 
 
Data collection and analysis: Two reviewers independently screened titles and abstracts. 
Full texts of potentially eligible papers were reviewed. Data were abstracted from, and a 
quality appraisal performed of, eligible papers.  
 
Main results: 23 papers reporting 16 studies were eligible. Colposcopy and related 
procedures can lead to adverse psychological outcomes, particularly anxiety. Ten studies 
investigated predictors of adverse psychological outcomes; management type and treatment 
had no impact on this. Seven studies investigated temporal trends in psychological 
outcomes post-colposcopy; findings were mixed, especially in relation to anxiety and 
distress. Studies were methodologically heterogeneous.  
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Conclusions: Follow-up investigations and procedures for abnormal cervical cytology can 
cause adverse psychological outcomes among women.  However, little is known about the 
predictors of these outcomes or how long they persist. There is a need for a more 
standardised approach to examining the psychological impact of colposcopy, especially 
longer-term outcomes.  
 
Keywords: systematic review, colposcopy, screening, cervix, adverse psychological 
outcomes, anxiety  
 
Introduction  
A colposcopy examination is one of the main follow-up options for women who undergo 
cervical screening and have an abnormal cytology result.1,2 At colposcopy women may have 
immediate treatment or have biopsies taken and be recalled later for treatment; clinical 
practice varies considerably between and within countries, and is often down to the 
discretion of the clinician. The adverse psychological impact of an abnormal cytology result is 
well recognised.3,4 Undergoing colposcopy can also be a distressing experience for women; 
numerous studies describe raised anxiety levels prior to and during the examination.5 
Evidence is now beginning to accrue that colposcopy and related management procedures, 
such as punch biopsies and large loop excision of the transformation zone (LLETZ), may be 
associated with major adverse psychological outcomes for some – and perhaps significant 
numbers of – women.6 However, little is known about which types of adverse psychological 
outcomes are most common, what are the predictors of these adverse psychological 
outcomes post-colposcopy, or what is their trajectory over time. 
 
A few reviews and overviews on the psychological impact of abnormal cytology, colposcopy 
and related interventions are available.7,8 However, these were not systematic and, having 
been published more than 10 years ago, do not include more recent studies. Moreover, to 
our knowledge, none focused specifically on women’s psychological wellbeing after (rather 
than before or during) colposcopy and/or related interventions. We, therefore, performed a 
systematic review to investigate: (1) what, if any, are the adverse psychological outcomes 
following colposcopy and related procedures?; (2)what are the predictors of adverse 
psychological outcomes post-colposcopy?; and (3) what happens to these adverse 
psychological outcomes over time post-colposcopy?  
 
Methods 
Search strategy 
We adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) guidelines in conducting this review and preparing the manuscript.9 We searched 
five databases (PubMed, PsychINFO, CINAHL, Web of Science and Scopus) to identify 
studies reporting psychological impacts of colposcopy and related procedures (henceforth 
referred to as “colposcopy” for brevity) published during January 1986-February 2014. 
Combinations of psychological, disease and intervention search terms were used 
(supplementary Figure S1). Psychological terms included anxiety, depression, distress, 
stress, wellbeing, emotion, mental, psychological, psychosocial, psychosexual, quality of life, 
and emotional states; disease terms included cervical smear, pap smear, cytological smear, 
cervix, cervical, cervical intraepithelial  neoplasia, CIN, cancer screening, and neoplasms; 
and intervention terms included colposcopy, conisation, ablation, cryotherapy, large loop 
excision of the transformation zone, LLETZ, LEEP, loop excision procedure, and laser. 
Wildcards and alternative spellings were used were appropriate. Reference lists from papers 
of eligible studies were checked to identify any potentially eligible articles which might have 
been missed by the electronic searches. Figure 1 shows the number of papers identified, 
screened and included. 
 
 
 
3 
 
Eligibility criteria 
Full details of inclusion and exclusion criteria are presented in Table S1. To be included 
papers had to report on one or more adverse psychological outcome(s) at one or more time-
points after colposcopy. Studies that assessed only health-related quality of life (HRQoL) or 
health utility, the psychological burden of HPV infection, or surrogates of psychological 
outcomes (such as anxiety assessed by women’s need to consult medical staff of clinic for 
reassurance) were excluded. The assessments had to be conducted at least one day after 
the colposcopy; studies which assessed women immediately after the procedure and while 
they were still at the clinic were not eligible. 
  
Data extraction 
Two reviewers (MOC, LS) independently screened titles and/or abstracts of records. Full text 
versions of papers considered potentially eligible for inclusion were read by both reviewers 
and their suitability for inclusion independently assessed. The reviewers then compared 
results and resolved any discrepancies.  Data were extracted from each eligible paper on: 
(1) study location; (2) study design; (3) study population; (4) psychological outcomes 
assessed (and tools used); (5) assessment time-points; (6) main results; (7) whether the 
study examined predictors of adverse psychological outcomes post-colposcopy?(and, if so, 
the findings); and (8) whether the study assessed temporal effects in outcomes (and, if so, 
the findings).  
 
Quality appraisal 
Full papers of eligible studies were critically appraised by the same two reviewers using a 
checklist based on established appraisal questions.10,11 Each paper was assessed on 11 
domains. Each domain was marked as “Yes” (Y), “No’’ (N), or “Partially” (P) based on the 
details reported in the paper (supplementary Table S2) and scored. One point was assigned 
for each “Yes”; 0.5 points for each “Partially” and no points for each “No”. A score of ≥8 was 
considered good quality, 4- 7 adequate quality and ≤3 poor quality. In addition the two 
reviewers also independently undertook a detailed critical appraisal of the methodology and 
reporting for each paper. 
 
Statistical analysis 
The study designs and methods, and the psychological outcomes assessed, were very 
heterogeneous so no formal statistical attempt was made to combine the findings.  
 
Results 
Study selection 
Initial searches yielded 1385 records, 1105 of which remained after removal of duplicates. 
1000 records were excluded on screening of titles/abstracts. The full text of the remaining 
105 articles was assessed; following this, 23 papers reporting 16 studies were eligible for 
inclusion. 
 
Study characteristics 
Of the 16 studies, four were randomised controlled trials, one was a non-randomised trial 
and 11 were observational studies (Table 1; abbreviated version and Table S3; full-length 
version). Seven studies were undertaken in the UK, two in Italy, two in The Netherlands and 
one each in Finland, Sweden, China, Thailand and the USA. Four stated that they included 
women who had cervical screening within organised programmes; this was unclear for other 
studies. The length of follow-up post-colposcopy ranged from 1 week to 30 months. A range 
of different psychological outcomes were assessed using a variety of instruments, some 
validated and some not. Supplementary Table S4 displays the instruments (and their 
abbreviations), the outcomes they measured and cut-offs used by the authors to define 
adverse effects. Response rates to post-colposcopy assessments were reported in eight 
studies and were 20%-88%. Ten studies (reported in 15 papers) investigated predictors of 
adverse psychological outcomes, considering a broad range of factors (e.g. age, 
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management received) (Table 2). Seven studies (eight papers) investigated temporal trends 
in adverse psychological outcomes post-colposcopy (Table 3). Twelve studies assessed 
psychological wellbeing at some time before colposcopy (or treatment) as well as post-
colposcopy.   
 
Paper quality  
20 papers scored ≥8 (good quality) and three papers scored in the range 4-7 (adequate 
quality). No papers were considered poor quality (Supplementary Table S2). Several 
weaknesses were identified on the further, detailed, critical appraisal of the studies. For 
example, some studies used non-validated instruments to assess adverse psychological 
outcomes in some studies. Some assessed psychological “outcomes” prior to receipt of 
colposcopy and biopsy results; this could impact on women’s subsequent psychological 
wellbeing. For most studies the authors failed to provide any rationale for the choice of the 
time-points at which to assess outcomes. In those studies which assessed 
sexual/psychosexual functioning, the distinction between sexual and psychosexual 
functioning was often unclear: for example, some studies claimed they assessed 
psychosexual functioning but in fact, most, if not all, of the questions in the instruments were 
on physical aspects of sexual functioning. 
 
Methodological heterogeneity 
Several sources of heterogeneity between studies were evident. The timepoints for the 
outcome assessments varied considerably among the studies. A diverse range of 
instruments was used to assess the adverse psychological outcomes. The location at which 
women completed the assessments varied: in some studies women were mailed the 
instruments to complete at home; in other studies women completed the instruments while at 
the colposcopy clinic; in other studies again women completed instruments at home at some 
timepoints and at the clinic at other timepoints.  
 
Adverse psychological outcomes following colposcopy  
Anxiety: Nine studies (16 papers) reported on anxiety in women after colposcopy (or 
treatment) (Table 1 and Table S3). Six studies (nine papers) measured post-colposcopy 
state anxiety using the STAI (Spielberger State-Trait Anxiety Inventory).12-21 Of these, one 
reported that 60% of women scored ≥ 35,14 the cut-off often used to define anxiety; another 
that 18% of women had high anxiety (defined as >44) at the first time-point post-
colposcopy21; and a third that the mean anxiety score among women who had undergone 
colposcopy was higher than the norm for adult women (defined as >36.2).20 A further three 
studies reported prevalence of anxiety post-colposcopy using various instruments; this was 
8%-29%.15,22-26 In one of these studies, 22-25 from the UK, prevalence post-colposcopy was 
lower than reported among the UK general female population but in another UK study it was 
higher.26 Three studies compared mean anxiety post-colposcopy to that among a control 
group; in all three, prevalence was higher in women who had had colposcopy.15,18,19,27 Eight 
studies compared anxiety at some point before colposcopy (or treatment) with that 
afterwards; of these, seven reported lower anxiety at the first post-colposcopy assessment 
than pre-colposcopy and, in two of these, the difference was  statistically significant.19,22,23 In 
the eighth study, anxiety levels did not change before and after colposcopy.16  
 
Depression: Depression post-colposcopy was reported in five studies (seven papers), 
assessed using different instruments (Table 1 and Table S3). Prevalence at the first 
assessment time-point post-colposcopy ranged from 7% to 22%.15,22-24,28 In the three studies 
with external control groups, depression was higher among women post-colposcopy than in 
the control group .15,19,27 Four studies compared depression pre- and post-colposcopy and in 
three, depression was lower at the first time-point post-colposcopy.15,19,27 In the fourth study, 
depression was slightly higher (but not significantly higher) at the first time-point post-
colposcopy compared to the pre-colposcopy assessment.23  
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Distress: Four studies (six papers) measured distress post-colposcopy, using different 
instruments (Table 1 and Table S3). One reported that one-third of women had procedure-
related distress at the first assessment time-point.6,22 Two studies used the 28-item General 
Health Questionnaire (GHQ)29 and, in both, mean GHQ scores at the first post-colposcopy 
assessment were below the usual cut-off for psychiatric distress.15,30 In the three studies 
which also conducted pre-colposcopy assessments, distress was lower at the first 
assessment post-colposcopy compared to pre-colposcopy.15,23,30 
 
Worries/fears about cancer and future fertility: In the single available study, just over one-
quarter of women were afraid of cancer and close to one-third had fears about future 
infertility at the first time-point post-colposcopy.19 These proportions were considerably lower 
than the proportions reporting these fears pre-colposcopy (Table 1 and Table S3).   
 
Sexual/psychosexual functioning: Seven studies (seven papers) assessed some aspect of 
sexual/psychosexual functioning post-colposcopy (Table 1 and Table S3). One used a 
validated instrument, the Female Sexual Function Index (FSFI)31 and reported that the mean 
total FSFI score post-colposcopy was above the cut-off for female sexual disorder.32  
 
Five studies compared pre- with post-colposcopy sexual/psychosexual functioning. Across a 
range of measures including sexual desire, sexual enjoyment/satisfaction, negative feelings 
about sex, frequency of intercourse, pain and lubrication during sex, results of the different 
studies were conflicting, with no consistent pattern of impact emerging. 15,18,20,32,33 
 
Predictors of adverse psychological outcomes following colposcopy  
The 10 studies (reported in 15 papers) which investigated predictors of adverse 
psychological outcomes varied in the characteristics and factors examined. 
  
Anxiety: Six studies (11 papers) examined whether post-colposcopy anxiety differed 
between subgroups (Table 2). Three studies of management received and post-colposcopy 
anxiety reported conflicting results; in two,17-19,23,24 management received was unrelated to 
anxiety post-colposcopy while in the other, anxiety was lower in women treated immediately 
compared to those who were recalled for treatment.13,14 In two studies, women with CIN2+ 
had higher anxiety scores than other women post-colposcopy.14,21 In one study, lower socio-
economic status was associated with higher anxiety levels post-colposcopy.14 One study 
reported that women who had particularly adverse responses to their initial abnormal 
cytology result were at significantly greater risk of anxiety post-colposcopy ,15 and another 
found that risk was significantly higher in women with higher fears about cancer and future 
fertility pre-colposcopy.19  
 
Depression: Three studies (six papers) assessed whether post-colposcopy depression 
varied between women (Table 2). In two, management received and whether or not 
treatment was performed were unrelated to subsequent depression levels.17,19,23,24 In the 
other, risk of depression was significantly higher in women who had a particularly adverse 
response to their initial abnormal cytology test result.15 
 
Distress: Two studies (three papers) investigated whether post-colposcopy distress differed 
between subgroups (Table 2). In one study, procedure-related distress was twice as 
common in women with (compared to those without) an abnormal transformation zone at 
colposcopy, and, in those with an abnormal transformation zone, risk of distress was raised 
in women with CIN2+ compared to other women. This study also found that lack of 
satisfaction with support following receipt of the abnormal cytology result was associated 
with distress six weeks post-colposcopy in women with a normal transformation zone,6 while 
the other study reported that lack of social support and more negative life events were 
related to longer-term distress.34 
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Worries/fears about cancer and future fertility: No studies examined which women were at 
greater risk of having worries about cancer and future infertility post-colposcopy. 
 
Sexual/psychosexual functioning: Four studies (four papers) examined whether particular 
women were at greater risk of experiencing adverse effects on their sexual or psychosexual 
functioning post-colposcopy (Table 2). In one study, type of treatment (LEEP or laser 
vaporisation) was unrelated to risk of these outcomes.35 One study reported that the adverse 
psychosexual effects after undergoing treatment by LEEP may be worse for 
postmenopausal than premenopausal women,36 but another found that age was unrelated to 
sexual/psychosexual functioning following treatment by LEEP.32  
 
What happens to adverse psychological outcomes over time post-colposcopy? 
Of the seven studies (eight papers) which examined the temporal pattern of psychological 
outcomes post-colposcopy, four assessed women at two time-points, one assessed women 
at three time-points and two assessed women at five time-points (Table 3).  
 
Anxiety: Five studies (six papers) examined the temporal pattern of anxiety post-colposcopy 
(Table 3), with heterogeneous findings. Three studies reported lower anxiety levels (or 
prevalence) at the second (3 months, 8 months and 2 years, respectively for the three 
studies) than the first time-point (1 month for two studies and 6 months for the third study) 
post-colposcopy;15,18,19,21 in one of these studies anxiety scores fell significantly over time .19 
The fourth study reported no change in mean anxiety scores between 6 months and 12 
months post-colposcopy16 and, in the fifth, the prevalence of anxiety increased significantly 
from the first (6 weeks) to the second time-point (12 months) post-colposcopy and remained 
stable at 18, 24 and 30 months.23 
 
Depression: Three studies (three papers) investigated temporal trends in depression post-
colposcopy (Table 3). Depression scores/levels did not change substantially over time in any 
study.  
 
Distress: Four studies (four papers) measured distress over time post-colposcopy. The level 
of distress declined over time in three studies,15,23,30 while in the other,34 it rose slightly at the 
second time-point post-colposcopy compared to the first before declining at the third, fourth 
and fifth time-points (Table 3).  
 
Worries/fears about cancer and future fertility: In the one available study, prevalence of 
cancer fears changed little change between 6 months and 2 years post-colposcopy (26% 
and 30%, respectively). Fears about future infertility decreased over the same time (from 
31% to 20%).19 
 
Sexual/psychosexual functioning: The single study which described temporal patterns in 
sexual/psychosexual functioning found different patterns depending on the specific outcome 
considered (Table 3). For example, ‘frequency of sex’ and ‘lubrication’ scores increased 
slightly over time, ‘spontaneous interest in sex’ and ‘orgasm’ scores did not change.18  
 
Discussion  
Main findings 
This systematic review, which included 23 papers reporting 16 separate studies, is the first 
to examine adverse psychological outcomes following colposcopy and related procedures. 
There was broad agreement among the studies that colposcopy can lead to adverse 
psychological outcomes for some women. Ten studies examined predictors of these 
outcomes. From the limited data available, management and treatment factors did not 
appear to affect the risk of adverse psychological outcomes, although women with CIN2+ 
may be at increased risk. Seven studies investigated what happens to adverse psychological 
outcomes over time post-colposcopy, with mixed results, particularly in relation to anxiety 
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and distress. Methodological heterogeneity between studies (e.g. diversity of instruments 
used, various different timepoints for assessment of outcomes) and weaknesses in design 
and reporting of individual studies made the adverse psychological outcomes difficult to 
quantify precisely; hence, although there are 23 papers on this topic, the exact magnitude of 
psychological impact specific to colposcopy (and/or related procedures) remains unknown.  
 
Strengths and limitations  
We followed recommended practice for conduct and reporting of systematic reviews.9 
Although we searched multiple databases, the possibility cannot be entirely excluded that 
relevant papers might have been missed. Another limitation is the absence of formal 
statistical combination of study results, but this was precluded by methodological 
heterogeneity. In addition, we did not consider ‘positive’ psychological outcomes (e.g. 
reassurance), but very few studies have reported on these.13,14 Although HPV testing has 
been introduced in the post-treatment setting in several countries,37-39 we did not consider 
HPV in this review largely because quantitative data has yet to emerge on whether HPV 
testing in this context impacts psychological wellbeing. Moreover, despite the changes in 
screening protocols internationally, colposcopy remains central to the management and 
follow-up of women with abnormal screening test results.  
 
Interpretation  
This review suggests that undergoing colposcopy (and related procedures) can result in 
adverse psychological consequences s for some women. Anxiety appears to be the most 
prominent outcome, with several studies suggesting higher levels post-colposcopy than 
population norms or control groups. However, although anxiety has been investigated more 
extensively than any other aspect of wellbeing, uncertainties remain in part due to limitations 
in study design. For example, two of the eight relevant studies measured anxiety one week 
following colposcopy13,14,27 when women who had undergone biopsy would still be waiting for 
results. As anxiety is a consequence of uncertainty,40 it is likely that the anxiety levels in 
these two studies were strongly influenced by the timing of the psychological assessment. In 
one study13,14, women who underwent immediate treatment were compared to women who 
had biopsies and were recalled for treatment if necessary; the psychological assessment 
was conducted one-week post-colposcopy. The study found that the women who underwent 
immediate treatment were significantly less anxious (and less embarrassed and more 
relieved) than other women, suggesting that that immediate treatment for abnormal cervical 
cytology may avoid certain adverse psychological outcomes. However, a randomised 
controlled trial of the immediate treatment versus biopsy and recall found no difference in 
anxiety over the longer-term between the two policies.23,24 
 
The evidence also suggests that other adverse psychological outcomes may be common 
post-colposcopy. For example, high proportions of women appear to experience procedure-
related distress after colposcopy, but this was only measured in one study (albeit a large 
population-based study).6,22 However, given the evidence that women can find undergoing 
the procedures stressful, painful and embarrassing,41-43 this finding seems plausible. There 
is also limited evidence that women may have fears about cancer and future infertility after 
colposcopy. However, these findings are also from one study, which included only 100 
women, meaning the estimates of prevalence of worries are rather imprecise. Still, they are 
consistent with emerging qualitative work which shows that women long-term distress after 
colposcopy is predominately related to concerns about fertility, cervical cancer and sexual 
intercourse.44  
 
Another striking finding is that surprisingly few studies looked at risk factors for experiencing 
adverse psychological outcomes, although such information seems essential to inform the 
development of interventions to alleviate adverse effects. In addition, the identification of 
potential predictors of post-colposcopy anxiety and distress is needed to help clinicians and 
other medical professionals better support and monitor the more ‘at-risk’ women attending 
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colposcopy clinics. A few positive associations were reported (e.g. women with CIN2+ had 
higher anxiety scores than other women post-colposcopy) but most of these were seen in 
single (or at the most two) studies13,14,21 and require confirmation. Moreover, most of the 
studies failed to take into account the fact that the risk factors considered may be inter-
related and only reported univariate results.    
 
Understanding the temporal trajectory of psychological wellbeing post-colposcopy is also 
crucial to inform the development of interventions.  Overall, depression does not appear to 
vary greatly after colposcopy;15,19,23 temporal trends in anxiety and distress were 
inconclusive,15,16,18,19,21,23,30,34 and changes in sexual/psychosexual functioning varied 
depending on the specific outcome considered.18 However, all of these conclusions must be 
viewed as preliminary given the relatively few relevant studies. Moreover, studies conducted 
assessments at very different time-points post-colposcopy (usually determined, as far as we 
can tell, pragmatically by the authors); only two conducted assessments at more than two 
time-points;21-23,25,34 and none followed women for more than 30 months. Of particular note, 
no studies investigated whether the adverse psychological outcomes persisted over time for 
the same women or whether it was different women affected at different time-points; this is 
an important gap in the literature. 
 
Although not the focus of this review, it was notable that most studies reported data which 
permitted the comparison of psychological wellbeing at some point pre-colposcopy and post-
colposcopy. In most instances, adverse effects declined after the colposcopy. It is plausible 
that undergoing some form of follow-up investigation for abnormal cytology provides 
reassurance that may resolve some of the anxiety and uncertainty women experience 
following receipt of an abnormal cytology result. Moreover, it seems likely that anxiety 
induced by receipt of abnormal cytology results is resolved in (at least some of) those 
women who receive a ‘normal’ colposcopy result. However, recently published findings 
suggest that notable proportions of women with a normal colposcopy experience long-term 
adverse psychological outcomes.45 
 
It was particularly noteworthy that a diverse range of instruments were used to assess 
psychological outcomes. Indeed some authors developed their own questionnaires despite 
the fact that validated instruments are available; it is unclear the extent to which these self-
developed instruments were validated, or psychometric properties assessed, prior to use. In 
addition, there was considerable variation in the cut-offs used for some instruments, with 
some studies choosing arbitrary cut-offs to define/categorise women with a particular 
outcome. Most studies used generalised or generic measures of outcomes (e.g. STAI, 
HADS, MADRS-S12,46,47), rather than focussing on more specific outcomes such as fears 
about cancer, concerns about fertility and impact on sexual relationships which have been 
reported in women who have abnormal cytology tests and follow-up.3,4 The exceptions to this 
were the study by Hellsten and colleagues19 (which considered fears of cancer and future 
fertility) and the TOMBOLA trial,6,23 which developed an instrument to measure context-
specific distress (i.e. distress associated specifically with having an abnormal cytology result 
and undergoing follow-up).48 Development of a more standardised approach to assess post-
colposcopy outcomes would help both advance knowledge in this area and inform 
interventions. 
 
Beyond the issue of outcome assessment, methodological heterogeneity was pronounced 
and makes it difficult to generalise the study findings to women who attend colposcopy 
clinics within organised screening programmes. Only four studies indicated clearly that study 
participants had participated in organised screening programmes.6,13,14,17-19,21-25 Several 
studies took place in a single colposcopy clinic/hospital15-20,26,27,39,32,33 and a few others 
involved multiple clinics in the same town/city;13,14,28 it is possible that women attending 
these clinics may not be representative of the entire population attending colposcopy. In 
general, source populations from which participants were recruited were poorly described. 
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Several studies had small sample sizes; seven of 16 included ≤100 women17-19,20,27,28,32-34 
and only two included ≥500 participants.6,14,22-25 Response/participation rates were often 
unclear.20,35,36 In those studies that reported response rates, they varied greatly.14-16,20-26,28 In 
addition, only a few studies provided information on non-participants (n=6).6, 13,14,23-26, ,28,30,34  
 
Conclusions 
This review suggests that women can experience adverse psychological outcomes following 
colposcopy and related procedures, particularly anxiety. It has also identified significant gaps 
in the literature. In particular, there is uncertainty about the exact magnitude of these 
adverse outcomes, their duration, and the factors that may place some women at increased 
risk. The methodological heterogeneity in the evidence-base indicates the need for a more 
standardised approach. Future work might usefully focus on the identification of appropriate 
timepoints for assessing adverse psychological outcomes and on developing consensus on 
a standardised assessment tool. Psychological burden is an important cost of cervical 
screening and merits further investigation.  
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10. Psychological outcome measures relevant, validated and 
described adequately 
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*Adapted from 'The pocket guide to critical appraisal' by Crombie,1996   and 
Jefferies et al. 2012                      
**The range of possible responses to each domain/question was "Yes (Y)", "No (N)", "Partially (P) ". Questions were only assigned a "Yes" (and a score of 1) if the detail necessary to fully 
answer the question was provided in the article; where the domain/question was dealt with to some extent, we assigned a response of "Partially" (and a score of 0.5). “No” was assigned a 
score of 0. ***e.g. women in general pop or women undergoing routine smear with normal result. ‡e.g. non-significant results described and discussed sufficiently. ‡‡e.g. multivariate analysis 
conducted where possible and appropriate. †e.g. inconsistencies in results explained, all relevant important outcomes considered. 
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Table S4. Instruments (and their) abbreviations, outcomes they measured and cut-offs used by 
various authors 
Abbreviation Instrument Outcome(s) Cut-off used to define 
adverse effect in 
included papers 
BDI Beck Depression 
Inventory 
Depression Score of ≥ 14 indicates 
mild depression(Gath et 
al. 1995) 
EORTC-QLQ-CX24 The European 
Organization for 
Research and Treatment 
of Cancer Quality-of-Life 
questionnaire cervical 
cancer module 
Disease-specific and 
treatment-specific aspects 
of QoL in patients with 
cervical cancer 
Outcomes of interest are 
subscales (e.g. Sexual 
functioning, sexual 
activity, sexual worry, 
sexual enjoyment) 
 
Authors did not use any 
cut-off(Sun et al. 2012) 
 
FSFI Female Sexual Function 
Index 
Female sexual functioning Authors did not use any 
cut-off (Serati et al. 
2010)*  
 
GHQ-28 28-Item General Health 
Questionnaire 
Distress A score of >4 indicates 
psychiatric 
caseness(Kitchener et al 
2004): a score of >5 
psychiatric morbidity(Gath 
et al 1995). For the 
purposes of this review 
mean/overall GHQ scores 
were looked at to define 
distress and not 
‘psychiatric casesness’ 
scores 
 
HADS Hospital Anxiety and 
Depression Scale 
Anxiety and depression Score of ≥ 11 indicates 
significant anxiety; score 
of ≥ 8 indicates significant 
depression; measures 
clinically significant 
anxiety and 
depression(Bell et al 
1995**, Cruickshank et al 
2005; Sharp et al 2013a; 
Sharp et al., 2013b; 
Sharp et al., 2011; 
TOMBOLA Group, 2009a; 
TOMBOLA Group 2009b, 
UK )  
 
IES Impact of Event Scale Procedure-related 
distress 
Score of ≥ 9 indicates 
significant distress(Sharp 
et al. 2013b; Sharp et al. 
2011) 
 
Leeds anxiety scale Leeds anxiety scale Anxiety Score of >6 indicates 
anxiety(Gath et al. 1995) 
 
Leeds depression scale Leeds depression scale Depression Score of > 6 indicates 
depression(Gath et al. 
1995) 
 
MADRS-S Montgomery–Åsberg 
Depression Rating Scale 
Depression Score of < 12 ‘normal’, 12 
- 20 ‘mild depression’, 
>20 ‘moderate to severe 
19 
 
depression’(Hellsten et al 
2009;2008b) 
 
PCQ Psychological 
Consequences 
Questionnaire 
Screen-specific anxiety Authors did not use any 
cut-off. Overall PCQ 
score ranges from 0 -36; 
higher scores indicate 
more dysfunction 
(Korfage et al. 2014) 
 
POMS Profile of Mood states Distress 
 
Authors did not use any 
cut-off(Tiersma et al. 
2005) 
 
POSM Process Outcome 
Specific Measure 
Context-specific distress Score of ≥median score 
used as cut-off(Sharp et 
al 2013a, Sharp et al. 
2011) 
 
PSE  Present State 
Examination 
PSE syndromes measure 
situational anxiety, 
somatic features of 
depression, and general 
anxiety 
Authors measured the 
prevalence of these 
syndromes & compared 
to a local community 
sample (Gath et al. 1995) 
 
SCID Structured Clinical 
Interview for DSM-III-R 
Depression  Criteria for depression 
according to DSM-III-
R
‡
(Savard et al. 1999) 
 
STAI  Spielberger State-Trait 
Anxiety Inventory 
Anxiety Score of >35 indicates 
anxiety(Balasubramani et 
al 2007;  Orbell et al. 
2004;Heinonen et al. 
2013; in one study  
authors compared the 
mean scores to mean 
STAI score of 36.2 for 
normal adult 
women(Howells et al. 
1999) 
‡‡ 
 
STAI-6 Six item short form 
Spielberger State-Trait 
Anxiety Inventory  
Anxiety Score of >44 was used to 
identify individuals who 
were highly anxious 
(Korfage et al. 2014) 
*a score of ≤ 26.55 indicates female sexual disorder(Ref: Wiegel M, et al. J Sex Marital Ther. 2005;31:1-20).** Bell et al 1995 
used a score of ≥11 to indicate significant depression. ‡Williams JBW, Gibbon M, First MB, Spitzer RL, Davies M, Borus J, 
Howes MJ, Kane J, Pope HG, Rounsaville B, Wittchen HU. The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite 
test–retest reliability. Arch Gen Psychiatry 1992;49:630–6. ‡‡Gath et al 1995, Hellsten et al 2009,2008a;2008b did not use any 
cut-off score for measuring anxiety using the STAI but instead compared the mean STAI scores to the scores of 
control/reference groups.  
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Figure S1. Search strategies for the five databases 
a) PubMed 
(((((((((((((anxiety[MeSH Terms]) OR anxiety) OR depression[MeSH Terms]) OR depression) 
OR distress) OR wellbeing) OR emotion[MeSH Terms]) OR emotion*) OR mental) OR 
psychological) OR psychosocial) OR psychosexual)) AND (((((((cervical smear[MeSH 
Terms])) OR pap smear OR cytological smear)) OR (((CIN* OR CIN *)) OR (cervix OR 
cervical)))) AND ((((((conization OR conization*) OR (ablation*) OR (cryotherapy) OR (large 
loop excision of the transformation zone) OR (LLETZ) OR (LEEP) OR (loop excision 
procedure*))) OR (colposcop*)) OR (laser)) NOT neck NOT spinal))  
 
b) PsychINFO 
((De “Anxiety” or De “Emotional States” or De “Stress” or De “Psychological Stress” or De 
“Distress”) AND (De “Cervix” or De “Cancer Screening” or De “Neoplasms”)) NOT cancer 
patients NOT children NOT childhood NOT caregiver NOT palliative NOT chemotherapy NOT 
prostate NOT colorectal* NOT breast NOT lung NOT ovarian NOT pancreatic NOT neck NOT 
sarcoma NOT testicular   
 
c) CINAHL 
(MH "Cervical Smears" or MH ‘’Cervical Intraepithelial Neoplasia’’) AND (MH ‘’Colposcopy’’) 
 
d) Web of Science 
((colposcop*) AND (cervical smear OR pap smear OR cytological smear OR cervical 
intraepithelial neoplasia) AND (wellbeing OR anxiety OR depression OR distress OR stress 
OR emotion* OR mental OR psychological OR psychosocial OR psychosexual OR quality of 
life) 
 
e) Scopus 
((ALL(cervical smear OR cervical intraepithelial neoplasia)) AND (ALL(colposcop*)) AND 
(ALL(wellbeing OR anxiety OR depression OR distress OR stress OR emotion* OR mental 
OR psychological OR psychosocial OR psychosexual OR quality of life))) 
  
 
 
